Lycopodium Limited
LYOPF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.60 | 0.89 | 0.07 | 0.10 |
| FCF Yield | 8.06% | 6.99% | 6.26% | 15.91% |
| EV / EBITDA | 5.52 | 4.29 | 2.62 | 3.35 |
| Quality | ||||
| ROIC | 22.04% | 33.45% | 30.18% | 20.56% |
| Gross Margin | 92.14% | 90.69% | 24.81% | 18.53% |
| Cash Conversion Ratio | – | – | 0.42 | 1.53 |
| Growth | ||||
| Revenue 3-Year CAGR | 1.02% | 14.64% | 27.01% | 3.44% |
| Free Cash Flow Growth | 31.70% | 73.94% | -59.22% | 338.45% |
| Safety | ||||
| Net Debt / EBITDA | -0.92 | -0.72 | -0.98 | -1.85 |
| Interest Coverage | 143.53 | 83.70 | 67.80 | 40.99 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 100.24 | 883.56 | 536.02 |
| Cash Conversion Cycle | 63.41 | 68.06 | 90.45 | 100.83 |